Real Check RIO: A Real-World Analysis of Nivolumab in First Line Metastatic Melanoma Assessing Efficacy, Safety and Predictive Factors

SIMPLE SUMMARY: With the recent advances of immunotherapy in the modern oncology era, the landscape of malignant melanoma has changed. However, it is not clear from the data across the various trials how to design the best therapeutic strategy. Hence, we decided to study the role of potential predic...

Descripción completa

Detalles Bibliográficos
Autores principales: Afrăsânie, Vlad-Adrian, Alexa-Stratulat, Teodora, Gafton, Bogdan, Froicu, Eliza-Maria, Sur, Daniel, Lungulescu, Cristian Virgil, Gherasim-Morogai, Natalia, Afrăsânie, Irina, Miron, Lucian, Marinca, Mihai-Vasile
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9953812/
https://www.ncbi.nlm.nih.gov/pubmed/36831607
http://dx.doi.org/10.3390/cancers15041265

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9953812/
https://www.ncbi.nlm.nih.gov/pubmed/36831607
http://dx.doi.org/10.3390/cancers15041265

Ejemplares similares